Physician profile
James Newman
NPI 1164783619
$297.46
in general payments reported to CMS, 2019-2025
6 companies · $72.24 in 2025
The $72.24 reported for 2025 was less than what a typical Sports Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.79 · 2020: $33.27 · 2021: $67.13 · 2022: $47.81 · 2023: $19.96 · 2024: $40.26 · 2025: $72.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $132.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrocision, INC. | $72.24 | 2025 | Tenjet |
| Depuy Synthes Sales INC. | $64.62 | 2019-2023 | Orthovisc |
| Pacira Pharmaceuticals Incorporated | $54.50 | 2021-2024 | Zilretta, Iovera, Exparel |
| Ferring Pharmaceuticals INC. | $48.50 | 2022-2024 | Euflexxa |
| Pacira Therapeutics, INC. | $35.18 | 2020-2021 | |
| Bioventus LLC | $22.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.